Arca
Skip to content
Tools
Tools

Penile cancer

Drug research and approvals for penile cancer: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 22, 2026, 28 studies of penile cancer are recruiting on ClinicalTrials.gov, and Health Canada has authorized 2 drug trials for it since 2013.

  • Recruiting worldwide: 28
  • Trials authorized in Canada: 2
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 28 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Phase 2 12

Phase 1 or earlier 4

How its trials ended

68 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 12 whose ending is known, 67% met their primary endpoint, 8% missed it and 25% stopped early.

  • Ongoing3146%
  • Completed, result not reported2131%
  • Met its primary endpoint812%
  • Status unknown46%
  • Stopped: enrollment or feasibility34%
  • Missed its primary endpoint11%

Trials authorized in Canada

Newest first; search them all in Canada trials
Apr 19, 2018International penile advanced cancer trial - inpactCisplatin/ Ifosfamide/ PaclitaxelCanadian Cancer Trials Group, Cancer Research Institute, Queen's UniversityOngoing
Jan 9, 2018A phase 2, multi-centre, open-label study of avelumab (MSB0010718C) in locally advanced or metastatic penile cancer patients unfit for platinum-based…MSB0010718C (avelumab)Princess Margaret Cancer CentreOngoing

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.